BOSTON SCIENTIFIC CORPORATION Funds and ETFs Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 75.61 USD | +1.65% |
|
+1.75% | +31.39% |
| May. 23 | Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing | MT |
| May. 23 | Medtronic beats quarterly profit estimates on medical devices strength | RE |
ETFs positioned on Boston Scientific Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.26% | 12 M€ | +15.09% | - | |
| 1.98% | 1 M€ | +2.21% | - | |
| 1.75% | 17 M€ | +7.15% | - | |
| 1.23% | 2 M€ | -1.17% | - | |
| 1.08% | 14 M€ | -5.30% | ||
| 1.03% | 10 M€ | +6.14% | - | |
| 0.78% | 265 M€ | +6.37% | - | |
| 0.66% | 9 M€ | -.--% | - | |
| 0.62% | 5 M€ | -72.95% | - | |
| 0.47% | 727 M€ | +8.98% | ||
| 0.38% | 25 M€ | +3.57% | - | |
| 0.37% | 2 M€ | 0.00% | ||
| 0.37% | 26 M€ | +16.85% | - | |
| 0.35% | 37 M€ | -.--% | ||
| 0.28% | 1 M€ | +0.04% | ||
| 0.27% | 36 M€ | +2.94% | - | |
| 0.26% | 559 M€ | +14.30% | ||
| 0.26% | 1,848 M€ | +18.39% | - | |
| 0.24% | 8 M€ | +7.26% | - | |
| 0.24% | 744 M€ | +9.15% | ||
| 0.22% | 26 M€ | +22.35% | - | |
| 0.22% | 1,174 M€ | +23.54% | ||
| 0.22% | 273 M€ | -.--% | ||
| 0.22% | 655 M€ | -.--% | - | |
| 0.21% | 6 M€ | +17.98% | - | |
| 0.21% | 121 M€ | +8.11% | - |
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
2024-05-29
- Bernstein Strategic Decisions Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
74.38
USD
Average target price
81.53
USD
Spread / Average Target
+9.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.39% | 109B | |
| +9.95% | 223B | |
| +13.59% | 194B | |
| +20.64% | 141B | |
| +2.05% | 64.85B | |
| +15.63% | 52.7B | |
| +3.96% | 51.77B | |
| +8.07% | 44.12B | |
| +3.63% | 36.21B | |
| +24.30% | 31.08B |
- Stock Market
- Equities
- BSX Stock
- Funds and ETFs Boston Scientific Corporation
